(URGN) Urogen Pharma complete technical analysis [charts+indicators] | Buy/Sell Urogen Pharma | (URGN) share price targets
Complete technical analysis of Urogen Pharma (URGN) by charts plus indicators, forecast predictions and share price targets for Urogen Pharma (URGN)
Urogen Pharma trades in USA in Health Care sector.
Showing technical analysis as on 2026-01-22 View latest technical analysis
10 day averaged volume of Urogen Pharma is 769865
| Date | Daily Closing Price | Open | High | Low | Volume |
| 22 Thu Jan 2026 | 20.00 | 19.14 | 20.12 | 19.09 | 1.015 times |
| 21 Wed Jan 2026 | 19.23 | 19.40 | 19.61 | 18.13 | 1.057 times |
| 20 Tue Jan 2026 | 19.33 | 18.20 | 19.38 | 18.20 | 0.739 times |
| 16 Fri Jan 2026 | 18.80 | 19.33 | 20.15 | 18.66 | 1.316 times |
| 15 Thu Jan 2026 | 19.54 | 18.73 | 19.64 | 18.35 | 1.347 times |
| 14 Wed Jan 2026 | 18.74 | 20.08 | 20.50 | 18.12 | 1.365 times |
| 13 Tue Jan 2026 | 19.83 | 21.53 | 21.65 | 19.76 | 1.283 times |
| 12 Mon Jan 2026 | 21.45 | 21.00 | 21.59 | 20.49 | 0.665 times |
| 09 Fri Jan 2026 | 21.25 | 23.59 | 24.10 | 21.18 | 1.107 times |
| 08 Thu Jan 2026 | 23.47 | 22.94 | 23.50 | 22.72 | 0.571 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 19.8 as stoploss in an intra day buy trade for a target of 21.58. However, stock will show a bearish move below 19.8.
Share price targets for Urogen Pharma (URGN)
| Target Type | Value |
| Downside Target | 15.86 |
| Downside Target | 17.05 |
| Downside Target | 18.12 |
| Upside Target | 20.12 |
| Upside Target | 20.99 |
| Upside Target | 22.44 |
| Upside Target | 22.60 |
| Upside Target | 23.81 |
| Upside Target | 24.10 |
| Upside Target | 24.14 |
| Upside Target | 28.87 |
| Upside Target | 30.00 |
Intraday share price targets for Urogen Pharma (URGN)
| Target Type | Value |
| Downside Intraday Target | 18.71 |
| Downside Intraday Target | 17.43 |
| Upside Intraday Target | 20.7 |
| Upside Intraday Target | 21.41 |
| Downside Intraday Target | 19.42 |
Weekly technical analysis of Urogen Pharma (URGN)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 22 Thu Jan 2026 | 20.00 | 18.20 | 20.12 | 18.13 | 0.47 times |
| 16 Fri Jan 2026 | 18.80 | 21.00 | 21.65 | 18.12 | 1.577 times |
| 09 Fri Jan 2026 | 21.25 | 22.59 | 24.10 | 20.99 | 1.249 times |
| 02 Fri Jan 2026 | 22.71 | 23.00 | 23.81 | 22.44 | 1.7 times |
| 26 Fri Dec 2025 | 23.03 | 23.00 | 24.14 | 22.60 | 0.243 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Urogen Pharma (URGN)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 22 Thu Jan 2026 | 20.00 | 23.70 | 24.10 | 18.12 | 0.566 times |
| 31 Wed Dec 2025 | 23.42 | 28.13 | 28.87 | 21.40 | 0.722 times |
| 28 Fri Nov 2025 | 28.81 | 20.27 | 30.00 | 18.15 | 1.085 times |
| 31 Fri Oct 2025 | 20.47 | 19.84 | 21.00 | 15.86 | 0.852 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Urogen Pharma (URGN)
Price action analysis of Urogen Pharma ( (URGN) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Urogen Pharma ( (URGN) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Urogen Pharma stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Urogen Pharma in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Urogen Pharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Urogen Pharma in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Urogen Pharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 19.89 and Urogen Pharma (URGN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Urogen Pharma (URGN) stock. Volume based technical analysis of Urogen Pharma (URGN) stock is negative.
Urogen Pharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Urogen Pharma ( (URGN) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Urogen Pharma stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Urogen Pharma in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Urogen Pharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Urogen Pharma in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Urogen Pharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 19.89 and Urogen Pharma (URGN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Urogen Pharma (URGN) stock. Volume based technical analysis of Urogen Pharma (URGN) stock is negative.
Urogen Pharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.